发布求助
文献互助 智能选刊 最新文献

从基因猎人到药物猎人

IF 101.8 1区 医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Nature Reviews. Drug Discovery Pub Date : 2025-08-14 DOI:10.1038/d41573-025-00139-2
Asher Mullard
{"title":"从基因猎人到药物猎人","authors":"Asher Mullard","doi":"10.1038/d41573-025-00139-2","DOIUrl":null,"url":null,"abstract":"Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development. Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"24 9","pages":"658-659"},"PeriodicalIF":101.8000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-025-00139-2.pdf","citationCount":"0","resultStr":"{\"title\":\"From gene hunter to drug hunter\",\"authors\":\"Asher Mullard\",\"doi\":\"10.1038/d41573-025-00139-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development. Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development.\",\"PeriodicalId\":19068,\"journal\":{\"name\":\"Nature Reviews. Drug Discovery\",\"volume\":\"24 9\",\"pages\":\"658-659\"},\"PeriodicalIF\":101.8000,\"publicationDate\":\"2025-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.nature.comhttps://www.nature.com/articles/d41573-025-00139-2.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Reviews. Drug Discovery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/d41573-025-00139-2\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews. Drug Discovery","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/d41573-025-00139-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

Howard Chang，安进的新CSO，讨论基因靶点的发现，染色体外DNA和技术的发展。
本文章由计算机程序翻译，如有差异，请以英文原文为准。

From gene hunter to drug hunter

分享
查看原文 本刊更多论文
From gene hunter to drug hunter
Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development. Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development.
求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
Nature Reviews. Drug Discovery
Nature Reviews. Drug Discovery 医学-生物工程与应用微生物
CiteScore
137.40
自引率
0.30%
发文量
227
期刊介绍： Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. Each issue includes: Highest-quality reviews and perspectives covering a broad scope. News stories investigating the hottest topics in drug discovery. Timely summaries of key primary research papers. Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信